166 related articles for article (PubMed ID: 28965572)
1. Anticancer properties of sodium selenite in human glioblastoma cell cluster spheroids.
Berthier S; Arnaud J; Champelovier P; Col E; Garrel C; Cottet C; Boutonnat J; Laporte F; Faure P; Hazane-Puch F
J Trace Elem Med Biol; 2017 Dec; 44():161-176. PubMed ID: 28965572
[TBL] [Abstract][Full Text] [Related]
2. Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells.
Hazane-Puch F; Arnaud J; Trocmé C; Faure P; Laporte F; Champelovier P
Anticancer Agents Med Chem; 2016; 16(4):490-500. PubMed ID: 26286659
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro.
Ribeiro DL; Latancia MT; de Souza I; Ariwoola AA; Mendes D; Rocha CRR; Lengert AVH; Menck CFM
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38717250
[TBL] [Abstract][Full Text] [Related]
4. A New Patient-Derived Metastatic Glioblastoma Cell Line: Characterisation and Response to Sodium Selenite Anticancer Agent.
Berthier S; Larrouquère L; Champelovier P; Col E; Lefebvre C; Cottet-Rouselle C; Arnaud J; Garrel C; Laporte F; Boutonnat J; Faure P; Hazane-Puch F
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30583471
[TBL] [Abstract][Full Text] [Related]
5. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carbonic anhydrase IX in glioblastoma multiforme.
Amiri A; Le PU; Moquin A; Machkalyan G; Petrecca K; Gillard JW; Yoganathan N; Maysinger D
Eur J Pharm Biopharm; 2016 Dec; 109():81-92. PubMed ID: 27702686
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.
Larrouquère L; Berthier S; Chovelon B; Garrel C; Vacchina V; Paucot H; Boutonnat J; Faure P; Hazane-Puch F
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638987
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
9. Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ.
Xu X; Wang Z; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Int J Oncol; 2018 Jul; 53(1):189-202. PubMed ID: 29749469
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.
Perazzoli G; Prados J; Ortiz R; Caba O; Cabeza L; Berdasco M; Gónzalez B; Melguizo C
PLoS One; 2015; 10(10):e0140131. PubMed ID: 26447477
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation.
Juric V; Hudson L; Fay J; Richards CE; Jahns H; Verreault M; Bielle F; Idbaih A; Lamfers MLM; Hopkins AM; Rehm M; Murphy BM
Cell Death Dis; 2021 Aug; 12(8):763. PubMed ID: 34344865
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
Huang H; Lin H; Zhang X; Li J
Oncol Rep; 2012 Jun; 27(6):2050-6. PubMed ID: 22426504
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
Jeong H; Park J; Shim JK; Lee JE; Kim NH; Kim HS; Chang JH; Yook JI; Kang SG
J Neurooncol; 2019 May; 143(1):69-77. PubMed ID: 30887242
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
Onzi GR; Ledur PF; Hainzenreder LD; Bertoni AP; Silva AO; Lenz G; Wink MR
Cytotherapy; 2016 Jul; 18(7):828-37. PubMed ID: 27210718
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
18. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.
Günther W; Pawlak E; Damasceno R; Arnold H; Terzis AJ
Br J Cancer; 2003 Feb; 88(3):463-9. PubMed ID: 12569392
[TBL] [Abstract][Full Text] [Related]
20. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
